More recently, different groups have shown that, even if CD95L can be detected on the surface of immune cells, the ligand is mainly found on the surface of endothelial cells lining blood vessels feeding cancer tissues (37, 53) or damaged organs in lupus patients (10, 36). Here, FASLG is linked to systemic lupus erythematosus.